THE STOCKHOLM DIRTY DOZEN
The term “Dirty Dozen” was coined at a convention held in Stockholm in 1995 to describe
12 important persistent organic pollutants (POPs), which were thought to be toxic
to human (and animal) health. These POPs were characterized by four features: Persistence,
bioaccumulation, potential for long-range environmental impact and toxicity.[1] A
later convention ratified this list, adding more to it. However, the term “Dirty Dozen”
has struck to the concept of POPs.
ENDOCRINE DISRUPTOR CHEMICALS
At about the same time, the term endocrine disruptor chemical (EDC) was coined to
describe chemicals that interfered with hormone synthesis and action thus producing
various endocrine anomalies, including those of the thyroid and gonads.[2] Most of
the POPs acted as EDCs, and a few of them were associated with diabetes, obesity and
metabolic disorders. Exposure to dichlorodiphenyltrichloroethane (DDT) in utero was
liked with a higher incidence of diabetes, use of bisphenol A was found to lead to
diabetes and obesity, while polychlorinated bisphenol were associated with diabetes
and obesity in children exposed prenatally to the same.[3]
OBESOGENS
A related group of compounds, the “obesogens,” which led to obesity in exposed individuals,
was also described. The obesogens linked with insulin resistance/diabetes include
bisphenol A, diethyl hexyl phthalate, perfluorooctanoate and organotins (tributylin).
These chemicals are found in the plastic industry, aerosols and paint industry, among
others. Other obesogens that find their way into humans include high-fructose corn
syrup, which is used as a sweetener in foods. The term obesogen also includes drugs
such as diethylstilboestrol, thiazolidinediones and certain anti-depressants.[4]
The multiplicity of pathogenic mechanism and associations being unearthed in diabetes
has meant that the “Dirty Dozen” or “diabetogens” have not received appropriate attention
in the current Indian or global medical literature. However, these diabetogens or
environmental metabolic disruptors (EMDs) deserve center stage in the study of diabetes.
Diabetes, much more so than most other endocrine diseases, is an ecosensitive disease:
Its etiology, clinical presentation, management and prognosis are intertwined with
the environment, both physical-natural and manmade, as well as human or social.
THE DIABETES ANTI-RAZOR
The use of the term “Dirty Dozen” in diabetes extends beyond what has just been discussed.
Traditional medical training teaches us to apply Occam's razor wherever possible,
trying to find a single etiology, pathogenetic mechanism or explanation for groups
of signs and symptoms, which may superficially appear disparate. Diabetes, however,
bucks the trend, and is one example where “anti-razors” hold way. Keeping this in
mind, we propose a re-look at the pathophysiology of diabetes, which is currently
described by the term “Ominous Octet,” so elegantly coined by Defronzo.[5]
THE DIRTY DOZEN OF DIABETES
We propose the addition of four well-known hormones to the list of players in diabetes
to bring the number to 12. All four hormones have adequate biochemical, epidemiological,
observational or clinical support to merit inclusion in the list of the Dirty Dozen
of Diabetes. Inclusion of all four players is linked with therapeutic implications
of significant importance for both patients and diabetes care professionals, for both
prevention and management of diabetes and associated metabolic complications.
CATECHOLAMINES, INCLUDING DOPAMINE
The ninth player that deserves to be mentioned alongside the Ominous Octet is the
catecholamine family. Dopamine, which is the catecholamine with highest concentration
in the brain, has already been termed “the forgotten felon”.[6] The dopamine modulator
drug bromocriptine is used for the management of type 2 diabetes in many countries
across the world, and has proven cardiovascular safety.[7] The autonomic nervous system
is also involved in the modulation of glycemia, in addition to the cerebral resistance
described by Defronzo.[5] Stress is linked with the onset of and with poor control
in diabetes.[8] Stress has been known to precipitate diabetic ketoacidosis, and diabetes
distress is commonly associated with poor control.
Appropriate use of non-pharmacological intervention, such as cognitive behavioral
therapy, coping skills training and stress management help in managing diabetes-associated
stress and stress-induced hyperglycemia. Judicial use of timed release bromocriptine
helps in resetting the sustained hyperdopaminergic tone that is characteristic of
many type 2 diabetes patients.
India has rightly been called a hyperadrenergic or dopaminergic nation. As we move
forward in development and modernization, we must try and avoid the stress that inevitably
accompanies such transition.[9]
VITAMIN D
Vitamin D plays an important role in both type 1 and type 2 diabetes. Acting as an
immunomodulatory hormone, it decreases pro-inflammatory cytokines, increases anti-inflammatory
cytokines, reduces autoimmune insulitis and protects agasinst type 1 diabetes in children
exposed to high doses of vitamin D in utero or in infancy. In adults, vitamin D is
linked with both insulin secretion and insulin sensitivity, and there is a strong
body of evidence, which justifies its inclusion in the Diabetes Dirty Dozen.[10]
Epidemiological evidence adds its weight to this recommendation. Low vitamin D levels
are associated with a higher prevalence of metabolic syndrome, diabetes, obesity,
hypertension, coronary artery disease and stroke.[10]
Being a vitamin D deficient nation, and a country of heliophobes, we can ill afford
to neglect the importance of vitamin D deficiency as a diabetogen if we wish to shed
the tag of “global diabetes capital.”
RENIN–ANGIOTENSIN SYSTEM
The classical impression of the renin–angiotensin system (RAS) as a linear cascade
limited to proteolysis has been replaced by an understanding of the multiple hormones,
enzymes and functions of this complicated system. Apart from its endocrine functions,
it has paracrine and autocrine effects, all of which are mediated by both circulating
and local RAS. RAS is present in many organs of the body, including the beta cell.
RAS–insulin signaling vitamin D cross-talk, which influences insulin secretion, has
been documented in the beta cell.[11] Vitamin D deficiency and obesity are also associated
with stimulation of RAS activity.[12]
Randomized controlled trials reveal a lower incidence of new-onset diabetes in patients
prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Because of this, and their nephroprotective and cardioprotective effects, these molecules
have become drugs of first choice in hypertension associated with diabetes.[13] While,
currently, they cannot be recommended for the primary prevention of diabetes, the
future holds promise for RAS-based intervention in diabetes care. RAS, therefore,
should justifiably be included as part of the Dirty Dozen.
TESTOSTERONE
The fourth hormone, which should be added to the list of diabetes players to complete
the Dirty Dozen, is testosterone.
Hypogonadism in men is associated with greater visceral fat, as the attenuating effect
of androgens on adipogenesis and cytokine production from adipocytes is lost. In diabetes,
low levels of FSH may cause lower androgen synthesis through local cytokines and may
lose its capacity to do so in diabetes. Mechanistic evidence such as this is buttressed
by clinical proof. Studies have shown that low testosterone precedes the onset of
diabetes, and androgen deprivation therapy exacerbates insulin resistance/worsens
glycemia in prostate cancer patients. As a corollary, androgen replacement in hypogonadal
men is found to improve insulin sensitivity/glycemic levels and reduce insulin requirements.[14]
These findings have important therapeutic implications. Physicians should screen for
hypogonadism in men with diabetes, while understanding that this condition affects
much more than sexuality. Low testosterone levels should certainly be treated, aiming
for high-normal values, but equally certainly should not be over-treated.
POST SCRIPT
If there is one disease that wields an anti-razor to Occam's law, it is diabetes.
We have highlighted four hormonal players, working in harmony in the diabetes orchestra,
to add to the Defronzo's Ominous Octet.
As the Dirty Dozen, including catecholamines, vitamin D, RAS and testosterone, impact
our understanding, diagnosis and management of diabetes, there are novel mechanisms
being discovered.
A positive association between high iron intake, high hemoglobin and diabetes mellitus
has been studied and discussed recently.[15] The exact mechanism of this has been
a matter of speculation however. As we go to press, Danish researchers have discovered
that increased activity of divalent metal transporter 1 protein damages the beta cell.
Removal of this iron transporter has been shown to protect murine models against diabetes.[16]
Whether this will be of clinical significance for iron-deficient India is a matter
of debate.
CONCLUSION
The final word regarding the pathophysiology of diabetes is yet to be written. As
we accept existence of the Dirty Dozen and perhaps, the Treacherous Thirteen (iron
included), we need to utilize every preventive and therapeutic strategy available
to us in order to halt the diabetes pandemic. Each of the known pathogenetic mechanisms
should be studied and assessed with an open mind for each individual patient in order
to achieve the best possible outcomes.